 | • レポートコード：QYR2104Z3787 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、片頭痛のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、点鼻薬、その他）、用途別市場規模（病院、クリニック、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・片頭痛の市場動向 ・企業の競争状況、市場シェア ・片頭痛の種類別市場規模（経口、注射、点鼻薬、その他） ・片頭痛の用途別市場規模（病院、クリニック、在宅ケア） ・片頭痛の北米市場規模2016-2027（アメリカ、カナダ） ・片頭痛のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・片頭痛のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・片頭痛の中南米市場規模2016-2027（メキシコ、ブラジル） ・片頭痛の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline、Allergan、Amgen、Eli Lilly、Teva Pharma、Biohaven Pharma、Abbott Laboratories、Johnson & Johnson、Valeant Pharma） ・結論 |
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. As of 2016 migraines is one of the most common causes of disability.
Market Analysis and Insights: Global Migraine Market
The global Migraine market size is projected to reach US$ 8537.5 million by 2026, from US$ 4867.7 million in 2019, at a CAGR of 8.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Migraine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Migraine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Migraine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Migraine market.
Global Migraine Scope and Market Size
Migraine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Migraine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injectable
Nasal Sprays
Others
Segment by Application
Hospitals
Clinics
Home Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
GlaxoSmithKline
Allergan
Amgen
Eli Lilly
Teva Pharma
Biohaven Pharma
Abbott Laboratories
Johnson & Johnson
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injectable
1.2.4 Nasal Sprays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Migraine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Migraine Market Perspective (2016-2027)
2.2 Migraine Growth Trends by Regions
2.2.1 Migraine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Migraine Historic Market Share by Regions (2016-2021)
2.2.3 Migraine Forecasted Market Size by Regions (2022-2027)
2.3 Migraine Industry Dynamic
2.3.1 Migraine Market Trends
2.3.2 Migraine Market Drivers
2.3.3 Migraine Market Challenges
2.3.4 Migraine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Players by Revenue
3.1.1 Global Top Migraine Players by Revenue (2016-2021)
3.1.2 Global Migraine Revenue Market Share by Players (2016-2021)
3.2 Global Migraine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Migraine Revenue
3.4 Global Migraine Market Concentration Ratio
3.4.1 Global Migraine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Revenue in 2020
3.5 Migraine Key Players Head office and Area Served
3.6 Key Players Migraine Product Solution and Service
3.7 Date of Enter into Migraine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Breakdown Data by Type
4.1 Global Migraine Historic Market Size by Type (2016-2021)
4.2 Global Migraine Forecasted Market Size by Type (2022-2027)
5 Migraine Breakdown Data by Application
5.1 Global Migraine Historic Market Size by Application (2016-2021)
5.2 Global Migraine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Migraine Market Size (2016-2027)
6.2 North America Migraine Market Size by Type
6.2.1 North America Migraine Market Size by Type (2016-2021)
6.2.2 North America Migraine Market Size by Type (2022-2027)
6.2.3 North America Migraine Market Size by Type (2016-2027)
6.3 North America Migraine Market Size by Application
6.3.1 North America Migraine Market Size by Application (2016-2021)
6.3.2 North America Migraine Market Size by Application (2022-2027)
6.3.3 North America Migraine Market Size by Application (2016-2027)
6.4 North America Migraine Market Size by Country
6.4.1 North America Migraine Market Size by Country (2016-2021)
6.4.2 North America Migraine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Migraine Market Size (2016-2027)
7.2 Europe Migraine Market Size by Type
7.2.1 Europe Migraine Market Size by Type (2016-2021)
7.2.2 Europe Migraine Market Size by Type (2022-2027)
7.2.3 Europe Migraine Market Size by Type (2016-2027)
7.3 Europe Migraine Market Size by Application
7.3.1 Europe Migraine Market Size by Application (2016-2021)
7.3.2 Europe Migraine Market Size by Application (2022-2027)
7.3.3 Europe Migraine Market Size by Application (2016-2027)
7.4 Europe Migraine Market Size by Country
7.4.1 Europe Migraine Market Size by Country (2016-2021)
7.4.2 Europe Migraine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Migraine Market Size (2016-2027)
8.2 Asia-Pacific Migraine Market Size by Type
8.2.1 Asia-Pacific Migraine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Migraine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Migraine Market Size by Type (2016-2027)
8.3 Asia-Pacific Migraine Market Size by Application
8.3.1 Asia-Pacific Migraine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Migraine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Migraine Market Size by Application (2016-2027)
8.4 Asia-Pacific Migraine Market Size by Region
8.4.1 Asia-Pacific Migraine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Migraine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Migraine Market Size (2016-2027)
9.2 Latin America Migraine Market Size by Type
9.2.1 Latin America Migraine Market Size by Type (2016-2021)
9.2.2 Latin America Migraine Market Size by Type (2022-2027)
9.2.3 Latin America Migraine Market Size by Type (2016-2027)
9.3 Latin America Migraine Market Size by Application
9.3.1 Latin America Migraine Market Size by Application (2016-2021)
9.3.2 Latin America Migraine Market Size by Application (2022-2027)
9.3.3 Latin America Migraine Market Size by Application (2016-2027)
9.4 Latin America Migraine Market Size by Country
9.4.1 Latin America Migraine Market Size by Country (2016-2021)
9.4.2 Latin America Migraine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Market Size (2016-2027)
10.2 Middle East & Africa Migraine Market Size by Type
10.2.1 Middle East & Africa Migraine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Migraine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Migraine Market Size by Type (2016-2027)
10.3 Middle East & Africa Migraine Market Size by Application
10.3.1 Middle East & Africa Migraine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Migraine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Migraine Market Size by Application (2016-2027)
10.4 Middle East & Africa Migraine Market Size by Country
10.4.1 Middle East & Africa Migraine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Migraine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Migraine Introduction
11.1.4 Pfizer Revenue in Migraine Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Migraine Introduction
11.2.4 GlaxoSmithKline Revenue in Migraine Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Migraine Introduction
11.3.4 Allergan Revenue in Migraine Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Migraine Introduction
11.4.4 Amgen Revenue in Migraine Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Migraine Introduction
11.5.4 Eli Lilly Revenue in Migraine Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 Teva Pharma
11.6.1 Teva Pharma Company Details
11.6.2 Teva Pharma Business Overview
11.6.3 Teva Pharma Migraine Introduction
11.6.4 Teva Pharma Revenue in Migraine Business (2016-2021)
11.6.5 Teva Pharma Recent Development
11.7 Biohaven Pharma
11.7.1 Biohaven Pharma Company Details
11.7.2 Biohaven Pharma Business Overview
11.7.3 Biohaven Pharma Migraine Introduction
11.7.4 Biohaven Pharma Revenue in Migraine Business (2016-2021)
11.7.5 Biohaven Pharma Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Migraine Introduction
11.8.4 Abbott Laboratories Revenue in Migraine Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Migraine Introduction
11.9.4 Johnson & Johnson Revenue in Migraine Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Valeant Pharma
11.10.1 Valeant Pharma Company Details
11.10.2 Valeant Pharma Business Overview
11.10.3 Valeant Pharma Migraine Introduction
11.10.4 Valeant Pharma Revenue in Migraine Business (2016-2021)
11.10.5 Valeant Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Migraine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of Nasal Sprays
Table 5. Key Players of Others
Table 6. Global Migraine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Migraine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Migraine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Migraine Market Share by Regions (2016-2021)
Table 10. Global Migraine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Migraine Market Share by Regions (2022-2027)
Table 12. Migraine Market Trends
Table 13. Migraine Market Drivers
Table 14. Migraine Market Challenges
Table 15. Migraine Market Restraints
Table 16. Global Migraine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Migraine Market Share by Players (2016-2021)
Table 18. Global Top Migraine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine as of 2020)
Table 19. Ranking of Global Top Migraine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Migraine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Migraine Product Solution and Service
Table 23. Date of Enter into Migraine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Migraine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Migraine Revenue Market Share by Type (2016-2021)
Table 27. Global Migraine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Migraine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Migraine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Migraine Revenue Market Share by Application (2016-2021)
Table 31. Global Migraine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Migraine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Migraine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Migraine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Migraine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Migraine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Migraine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Migraine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Migraine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Migraine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Migraine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Migraine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Migraine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Migraine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Migraine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Migraine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Migraine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Migraine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Migraine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Migraine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Migraine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Migraine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Migraine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Migraine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Migraine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Migraine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Migraine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Migraine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Migraine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Migraine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Migraine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Migraine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Migraine Product
Table 66. Pfizer Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Migraine Product
Table 71. GlaxoSmithKline Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Allergan Company Details
Table 74. Allergan Business Overview
Table 75. Allergan Migraine Product
Table 76. Allergan Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 77. Allergan Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Migraine Product
Table 81. Amgen Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Eli Lilly Company Details
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Migraine Product
Table 86. Eli Lilly Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly Recent Development
Table 88. Teva Pharma Company Details
Table 89. Teva Pharma Business Overview
Table 90. Teva Pharma Migraine Product
Table 91. Teva Pharma Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 92. Teva Pharma Recent Development
Table 93. Biohaven Pharma Company Details
Table 94. Biohaven Pharma Business Overview
Table 95. Biohaven Pharma Migraine Product
Table 96. Biohaven Pharma Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 97. Biohaven Pharma Recent Development
Table 98. Abbott Laboratories Company Details
Table 99. Abbott Laboratories Business Overview
Table 100. Abbott Laboratories Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 101. Abbott Laboratories Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Migraine Product
Table 105. Johnson & Johnson Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 106. Johnson & Johnson Recent Development
Table 107. Valeant Pharma Company Details
Table 108. Valeant Pharma Business Overview
Table 109. Valeant Pharma Migraine Product
Table 110. Valeant Pharma Revenue in Migraine Business (2016-2021) & (US$ Million)
Table 111. Valeant Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Nasal Sprays Features
Figure 5. Others Features
Figure 6. Global Migraine Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Home Care Case Studies
Figure 10. Migraine Report Years Considered
Figure 11. Global Migraine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Migraine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Migraine Market Share by Regions: 2020 VS 2027
Figure 14. Global Migraine Market Share by Regions (2022-2027)
Figure 15. Global Migraine Market Share by Players in 2020
Figure 16. Global Top Migraine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Migraine as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Migraine Revenue in 2020
Figure 18. Global Migraine Revenue Market Share by Type (2016-2021)
Figure 19. Global Migraine Revenue Market Share by Type (2022-2027)
Figure 20. North America Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Migraine Market Share by Type (2016-2027)
Figure 22. North America Migraine Market Share by Application (2016-2027)
Figure 23. North America Migraine Market Share by Country (2016-2027)
Figure 24. United States Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Migraine Market Share by Type (2016-2027)
Figure 28. Europe Migraine Market Share by Application (2016-2027)
Figure 29. Europe Migraine Market Share by Country (2016-2027)
Figure 30. Germany Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Migraine Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Migraine Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Migraine Market Share by Region (2016-2027)
Figure 40. China Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Migraine Market Share by Type (2016-2027)
Figure 48. Latin America Migraine Market Share by Application (2016-2027)
Figure 49. Latin America Migraine Market Share by Country (2016-2027)
Figure 50. Mexico Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Migraine Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Migraine Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Migraine Market Share by Country (2016-2027)
Figure 56. Turkey Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Migraine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Migraine Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Migraine Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Migraine Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Migraine Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Migraine Business (2016-2021)
Figure 64. Teva Pharma Revenue Growth Rate in Migraine Business (2016-2021)
Figure 65. Biohaven Pharma Revenue Growth Rate in Migraine Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Migraine Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Migraine Business (2016-2021)
Figure 68. Valeant Pharma Revenue Growth Rate in Migraine Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の脳幹前兆薬による片頭痛市場規模・現状・予測（2021年-2027年） A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occu…- 世界の片頭痛治療薬市場規模・現状・予測（2021年-2027年） Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs. Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes wi…
- 世界の片頭痛治療市場規模・現状・予測（2021年-2027年） Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP mon…
- 世界の片頭痛治療市場規模・現状・予測（2021年-2027年） Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP mon…
- 世界の吸入・点鼻薬ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inhalation and Nasal Sprays Generic Drugs Market The global Inhalation and Nasal Sprays Generic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…